Acadia Pharmaceuticals Inc (ACAD) stock
ACADNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3041% below fair value
$18.75+0.61 (+3.36%)
Close on Nov 13, 2026Market cap $3.23BP/E 8.9Yield –
Acadia Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Acadia Pharmaceuticals's cash was $976.45M at Sep 30, 2026. For fiscal 2025 it was $819.69M, up 8.4% from the year before. Over ten years it grew 14.3% a year on average. The highest annual figure on record is $819.69M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $819.69M | +8.4% |
| FY2024 | Dec 31, 2024 | $755.99M | +72.3% |
| FY2023 | Dec 31, 2023 | $438.87M | +5.3% |
| FY2022 | Dec 31, 2022 | $416.82M | -20.0% |
| FY2021 | Dec 31, 2021 | $520.71M | -17.6% |
| FY2020 | Dec 31, 2020 | $631.96M | -9.4% |
| FY2019 | Dec 31, 2019 | $697.43M | +47.3% |
| FY2018 | Dec 31, 2018 | $473.52M | +38.7% |
| FY2017 | Dec 31, 2017 | $341.34M | -35.5% |
| FY2016 | Dec 31, 2016 | $529.04M | +145.9% |
| FY2015 | Dec 31, 2015 | $215.13M | -33.3% |
| FY2014 | Dec 31, 2014 | $322.49M | +73.6% |
| FY2013 | Dec 31, 2013 | $185.79M | +72.1% |
| FY2012 | Dec 31, 2012 | $107.97M | +247.7% |
| FY2011 | Dec 31, 2011 | $31.05M | -16.3% |
| FY2010 | Dec 31, 2010 | $37.09M | +104.7% |
| FY2009 | Dec 31, 2009 | $18.12M | -14.4% |
| FY2008 | Dec 31, 2008 | $21.17M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $976.45M | +15.3% |
| Q2 FY2026 | Jun 30, 2026 | $956.47M | +25.5% |
| Q1 FY2026 | Mar 31, 2026 | $851.46M | +24.9% |
| Q4 FY2025 | Dec 31, 2025 | $819.69M | +8.4% |
| Q3 FY2025 | Sep 30, 2025 | $847.02M | +49.8% |
| Q2 FY2025 | Jun 30, 2025 | $762.00M | +52.1% |
| Q1 FY2025 | Mar 31, 2025 | $681.58M | +44.9% |
| Q4 FY2024 | Dec 31, 2024 | $755.99M | +72.3% |
| Q3 FY2024 | Sep 30, 2024 | $565.33M | +63.4% |
| Q2 FY2024 | Jun 30, 2024 | $500.94M | +33.5% |
| Q1 FY2024 | Mar 31, 2024 | $470.52M | +16.8% |
| Q4 FY2023 | Dec 31, 2023 | $438.87M | +5.3% |
| Q3 FY2023 | Sep 30, 2023 | $345.92M | -20.8% |
| Q2 FY2023 | Jun 30, 2023 | $375.38M | -14.0% |
| Q1 FY2023 | Mar 31, 2023 | $402.87M | -9.7% |
| Q4 FY2022 | Dec 31, 2022 | $416.82M | -20.0% |
| Q3 FY2022 | Sep 30, 2022 | $436.58M | -19.2% |
| Q2 FY2022 | Jun 30, 2022 | $436.35M | -21.6% |
| Q1 FY2022 | Mar 31, 2022 | $445.98M | -22.8% |
| Q4 FY2021 | Dec 31, 2021 | $520.71M | -17.6% |
| Q3 FY2021 | Sep 30, 2021 | $540.29M | -16.2% |
| Q2 FY2021 | Jun 30, 2021 | $556.92M | -15.4% |
| Q1 FY2021 | Mar 31, 2021 | $577.77M | -11.3% |
| Q4 FY2020 | Dec 31, 2020 | $631.96M | -9.4% |
| Q3 FY2020 | Sep 30, 2020 | $644.44M | -5.8% |
| Q2 FY2020 | Jun 30, 2020 | $658.55M | +72.4% |
| Q1 FY2020 | Mar 31, 2020 | $651.41M | +57.2% |
| Q4 FY2019 | Dec 31, 2019 | $697.43M | +47.3% |
| Q3 FY2019 | Sep 30, 2019 | $683.85M | +219.4% |
| Q2 FY2019 | Jun 30, 2019 | $381.89M | +48.7% |
| Q1 FY2019 | Mar 31, 2019 | $414.32M | +39.0% |
| Q4 FY2018 | Dec 31, 2018 | $473.52M | +38.7% |
| Q3 FY2018 | Sep 30, 2018 | $214.14M | -41.6% |
| Q2 FY2018 | Jun 30, 2018 | $256.86M | -38.5% |
| Q1 FY2018 | Mar 31, 2018 | $298.06M | -36.5% |
| Q4 FY2017 | Dec 31, 2017 | $341.34M | -35.5% |
| Q3 FY2017 | Sep 30, 2017 | $366.63M | – |
| Q2 FY2017 | Jun 30, 2017 | $417.32M | – |
| Q1 FY2017 | Mar 31, 2017 | $469.48M | – |
| Q4 FY2016 | Dec 31, 2016 | $529.04M | – |
See a number that looks wrong?